a new antiarrhythmic agent , 1- ( 2,6- dimethylphenoxy ) -2-aminopropane ( mexiletine ) , was investigated in 10 patients with chronic premature ventricular contractions ( pvcs ) to evaluate the antiarrhythmic efficacy and the pharmacokinetics after single intravenous , single oral and repeated oral dosings of mexiletine 150 mg .
C0003195
antiarrhythmic
C0025887
mexiletine